Researchers continue to excited about the medication , a innovative dual agonist showing significant results in initial trials for size reduction . It acts by modulating both pathways : GLP-1 and GIP, https://amaanwkpb449615.ja-blog.com/41065685/a-new-possibility-for-size-loss